152results about How to "More convenient" patented technology

A method of controlling a mobile device configured with a touch-sensitive display and a motion sensor is provided. The method includes: the step of detecting a contact with the touch-sensitive display while the mobile device is in a first state to determine whether the detected contact corresponds to a predefined icon; the step of detecting a rotation or movement with the motion sensor while the mobile device is in the first state to determine whether the detected rotation or the movement corresponds to a predefined gesture; and the step of transitioning the mobile device to a second state when the detected contact corresponds to the predefined icon, and the detected rotation or movement corresponds to the predefined gesture. The mobile device is also provided.

The present invention features compositions, methods, and kits useful in the treatment of viral diseases. In certain embodiments, the viral disease is caused by a single stranded RNA virus, a flaviviridae virus, or a hepatic virus. In particular embodiments, the viral disease is viral hepatitis (e.g., hepatitis A, hepatitis B, hepatitis C, hepatitis D, hepatitis E). Also featured are screening methods for identification of novel compounds that may be used to treat a viral disease.

The invention features compositions, methods, and kits for the treatment of metabolic disorders such as diabetes and obesity.

The present invention features compositions, methods, and kits useful in the treatment of viral diseases. In certain embodiments, the viral disease is caused by a single stranded RNA virus, a flaviviridae virus, or a hepatic virus. In particular embodiments, the viral disease is viral hepatitis (e.g., hepatitis A, hepatitis B, hepatitis C, hepatitis D, hepatitis E) and the agent or combination of agents includes sertraline, a sertraline analog, UK-416244, or a UK-416244 analog. Also featured are screening methods for identification of novel compounds that may be used to treat a viral disease.

The invention features a method for treating a patient diagnosed with, or at risk of developing, an immunoinflammatory disorder by administering a non-steroidal immunophilin-dependent immunosuppressant (NsIDI) and a Group A enhancer (e.g., antifungal agent, antigout agent, anti-infective agent, antiprotozoal agent, antiviral agent, humectant, sunscreen, vitamin D compound, microtubuline inhibitor, or zinc salt) or analog or metabolite thereof to the patient. The invention also features a pharmaceutical composition containing an NsIDI and Group A enhancer or analog or metabolite thereof for the treatment or prevention of an immunoinflammatory disorder.

A color matching and color recommendation system. In one embodiment, the system may (i) receive a color input indicative of one or more colors, (ii) select at least one reference color from the one or more colors, (iii) associate the at least one reference color with at least one of a plurality of predefined color categories, and (iv) identify at least one related color based on the at least one of the plurality of predefined color categories. In another embodiment, the system may (i) receive a color input indicative of one or more colors, (ii) select at least one reference color from the one or more colors, and (iii) compare the at least one reference color to a plurality of predetermined colors to identify one or more related colors having color data closest to the at least one reference color.

A retail store network comprising a cash register, server, and hand held optical reader for reading a bar code symbol of an item and generating a decoded out bar code data message. The hand held bar code reader has an electrical connector and a wireless transceiver. The optical reader can be used with a base unit also having an electrical connector and a wireless transceiver. The network is configured so that the hand held bar code reader and the base unit have one linking mode in which the address of the base unit is sent to the hand held bar code reader through their respective electrical connectors. The linking process is completed by way of wireless communication, including the transmission of the address of the hand held bar code reader to the base unit. The hand held bar code reader further comprises circuitry to allow the optical reader to also operate in a linking mode where it can link with other devices that it cannot physically mate its electrical connector with, but can initiate the linking and complete the process wirelessly.

The invention features a method for treating a patient diagnosed with, or at risk of developing, an immunoinflammatory disorder by administering to the patient an antihistamine, either alone or in combination with one or more additional agents. The invention also features a pharmaceutical composition containing an antihistamine in combination with one or more additional agents.

The invention features methods, compositions, and kits for treating an immunoinflammatory disorder, an ophthalmic disorder, a musculoskeletal disorder or pain associated therewith, a periodontal disease, or a disease or condition associated with an increased serum CRP level.

Methods, systems, computer-readable media, and apparatuses for obtaining updated navigation information are presented. A first computing device can receive routing information from a second computing device, where the routing information is indicative of a route determined by the second computing device to a destination. Subsequently, navigation instructions can be provided at the first computing device based upon the routing information received from the second computing device. The first computing device then can receive, from the second computing device, a change to the routing information. Thereafter, and responsive to receiving the change to the routing information, the first computing device can provide modified navigation instructions.

The present invention relates to pharmaceutical dosage forms of a combination of carbidopa and levodopa comprising both immediate release and controlled release components for the treatment of ailments associated with depleted amounts of dopamine in a patient's brain tissue, which dosage forms display no food effect or at least substantially avoid the food effect, and a related method of treatment for a patient in which the bioavailability of levodopa under non-fasting conditions is equivalent to the bioavailability under fasting conditions.

The invention provides a currency selectable stored value instrument, whose currency may be chosen or converted at the time value is loaded, after load but prior to redemption of value, at the time of redemption, or at other times. One embodiment of the system is configured so that the stored value instrument may be a plastic card with a magnetic stripe, compatible with card readers on Automated Teller Machines (ATMs) or other terminals. In one embodiment, U.S. dollars may be converted to Mexican pesos when the stored value instrument is loaded at an ATM or other location in the United States. A user may subsequently redeem that value for legal tender in pesos at an ATM located in Mexico, for example, or for goods, services, or cash in other currencies.

The invention features a method for treating a patient diagnosed with, or at risk of developing, an immunoinflammatory disorder by administering to the patient a tetra-substituted pyrimidopyrimidine, either alone or in combination with one or more additional agents. The invention also features a composition containing a tetra-substituted pyrimidopyrimidine in combination with one or more additional agents.

The invention features compositions including two, three, or more agents useful in treating a patient with a neoplasm, methods for treatment of a patient with a neoplasm such as cancer (e.g., brain cancer), kits which include one, two, three, or more agents useful in the treatment of cancer, as well as methods for identifying combinations of compounds potentially useful in treating a patient with a neoplasm.

The invention features a method for treating a patient diagnosed with, or at risk of developing, an immunoinflammatory disorder by administering to the patient a tetra-substituted pyrimidopyrimidine, either alone or in combination with one or more additional agents. The invention also features a composition containing a tetra-substituted pyrimidopyrimidine in combination with one or more additional agents.

A wall adaptor includes an adaptor body, a terminal unit and a connector module. The terminal unit is disposed on the adaptor body and has a pin arrangement, and the connector module is detachably disposed on the adaptor body. The connector module has a module body and at least a first connector disposed on the adaptor body, the connector module and the adaptor body are in electrical communication through electrical contacts. The connector module is replaceable for broader implementation.

PCT No. PCT / GB94 / 00865 Sec. 371 Date Feb. 18, 1997 Sec. 102(e) Date Feb. 18, 1997 PCT Filed Apr. 22, 1994 PCT Pub. No. WO94 / 25286 PCT Pub. Date Nov. 10, 1994Folded sheet means (201, 10) (e.g. substantially one-half or one-third of credit card size) (e.g. in the form of a kit of parts) comprises a sheet (221, 12) of paper or like material with a first set of concertina folds (261, 14) and a second set of concertina folds (281, 16) transverse to the first set, at which folds (261, 281, 14, 16) the sheet (221, 12) can be folded and unfolded, connection means (1061, 52) adapted to serve as or as part of means for releasably connecting between the folded sheet means (201, 10) and another object, and holding means (241, 22, 24) adapted for releasably holding the folded sheet means folded. Said holding means comprises an envelope or other container (241), said sheet (221) being adapted to be retained therein, e.g. with the aid of friction and / or at least one inwardly directed lip (341). The folded sheet material (221) may be (e.g. removably) in a carrier (961) movable into and out from the container (241). A tail (1061) suitable for connection to a key-ring, luggage or other portable object is provided, e.g. on the carrier (961). The container (241) may comprise two sheet-like portions (401, 421) hinged together and adapted to be releasably fastened together about the folded sheet (221). Two stiff portions (18, 20) are in diagonally opposite corners respectively of the sheet (12) when it is unfolded, and said holding means comprise a releasable connection (22), e.g. two tongues (26, 28) extending from one of said stiff portions (18) inwardly thereof in opposite directions. Part or all of the connection means (522, 523, 662) may be provided in common with part or all of the holding means (522,523, 662). The folded sheet means (10) may have a back portion (138) provided with releasable self-adhesive material for attaching it to a holding surface (107) and a front portion (208) adapted for grasping and opening the sheet (12).

The invention features compositions, methods, and kits useful for the treatment of filovirus-mediated diseases, e.g., hemorrhagic fever caused by Ebola virus, in an animal.

The invention features methods for identifying new combination therapies for the treatment of cancer and other proliferative diseases.

A retail store network comprising a cash register, server, and hand held optical reader for reading a bar code symbol of an item and generating a decoded out bar code data message. The hand held bar code reader has an electrical connector and a wireless transceiver. The optical reader can be used with a base unit also having an electrical connector and a wireless transceiver. The network is configured so that the hand held bar code reader and the base unit have one linking mode in which the address of the base unit is sent to the hand held bar code reader through their respective electrical connectors. The linking process is completed by way of wireless communication, including the transmission of the address of the hand held bar code reader to the base unit. The hand held bar code reader further comprises circuitry to allow the optical reader to also operate in a linking mode where it can link with other devices that it cannot physically mate its electrical connector with, but can initiate the linking and complete the process wirelessly.

It is an object of the present invention to overcome the limitations of the prior art through the use of a wireless management interface (WMI). The WMI enables a user to securely manage the wireless transfer and synchronization of data between two or more wireless-equipped devices. The WMI is preferably implemented in a combination of hardware and software and operates by enabling a user, via a graphical display and user input capabilities, to establish a communication profile for any two or more devices. The communication profile includes one or more content parameters and one or more timing parameters. In response to receiving configuration instructions from the WMI, the devices then operate to transfer or synchronize designated content at a designated time according to the communication profile. Synchronization is further facilitated by a database that is accessible to the WMI and maintains the communication profiles and other device-specific configuration information.

The invention features combinations of drugs for the treatment of proliferative diseases (e.g., cancer). The invention also features methods for identifying new combination therapies for the treatment of cancer and other proliferative diseases.

Provided is a storage controller having at least one or more first logical devices to be accessed by the host system, and at least one or more virtual devices for connecting the first logical devices and one or more storage devices. At least one of the virtual devices is connected to a second logical device of the other storage controller. With this storage controller, the access attribute of the first logical device and the access attribute of the second logical device are made to coincide by transmitting and receiving access attribute information of at least either the first logical device or the second logical device to and from the second storage controller.

The present invention offers a useful, novel, and non-obvious means of safely and quickly verifying and calibrating fluid flow instrumentation responsible for the accurate measurement and reporting of various forms of fluid flow rates, including but not limited to the verification and calibration of the fluid flow instrumentation responsible for the measurement and reporting of greenhouse gas emission rates.The present invention introduces major modifications into the field of fluid flow meter calibration and verification and into the field of on-site use of standardized Coriolis flow meters as reference meters (also called “Master Meters”) under procedures such as those set out in the International Organization for Standardization (ISO) Standard No. 10790:1999 (E), for fluid flow meter calibration and verification.The present invention introduces to the field a portable, self-contained system for on-site (field) fluid flow meter calibration and / or verification and eliminates many demands for resources typically placed on manufacturing facilities during fluid flow meter calibration and verification procedures.The present invention includes provision for the convenient and environmentally responsible disposal of contaminated and / or potentially hazardous waste material at authorized locations and thereby creates an atmosphere of enhanced occupational safety for the manufacturing facility requesting on-site fluid flow meter calibrations.

The invention features methods, compositions, and kits for treating a musculoskeletal disorder, e.g., osteoarthritis, or pain, fatigue, tenderness, impairment in mobility, soft tissue swelling, or bony swelling associated therewith, by administering to a patient diagnosed with or at risk of developing such pain, fatigue, tenderness, impairment in mobility, soft tissue swelling, or bony swelling a tetra-substituted pyrimidopyrimidine, e.g., dipyridamole, or an adenosine activity upregulator, in combination with one or more additional agents. The invention further features methods, compositions, and kits for treating a patient diagnosed with or at risk of developing a musculoskeletal disorder by administering to the patient a tetra-substituted pyrimidopyrimidine or an adenosine activity upregulator in combination with one or more additional agents.

Disclosed herein is a camera lens module pop-up device for a portable wireless terminal which enables insertion and extraction of a camera lens module into and from the portable wireless terminal in a pop-up manner. The device comprises a terminal housing formed with a lens hole, a camera lens module coupled through the lens hole in such a fashion that it can be inserted into or extracted from the lens hole as it is pushed laterally, and can rotate about a hinge axis thereof when being extracted, a rotation cam unit provided at an end surface of the camera lens module for adjusting or restraining a rotation angle of the camera lens module in a stepwise manner when the camera lens module is extracted from the lens hole, and a lens pop-up module coupled to the camera lens module so as to extend in a hinge axis direction for enabling the camera lens module to be inserted and extracted through the lens hole when the camera lens module is pushed laterally, and for enabling the camera lens module to rotate upon extraction thereof.

The invented device enables the player of a musical instrument to monitor an electrical audio signal by bone conduction during playing. A conductively emitting surface, comprising an electromechanical transducer driven by the electrical audio signal to be monitored, is disposed on the exterior of the musical instrument to contact a conductively receptive exterior surface of the player's body near a bony structure of the player's head. In the most preferred embodiment, the musical instrument is a chin-supported stringed instrument, the instrument chinrest comprises the conductively emitting surface, and the conductively receptive exterior body surface is skin overlying the player's mandible. Acoustic energy produced by the electromechanical transducers is conducted from the conductively emitting surface to bones of the head, causing perception of the audio information contained in the electrical audio signal. The device provides simple, sanitary, discreet, and private monitoring of useful signals during performance, recording, or practicing.

The invention provides methods for the treatment of major depressive disorder in male subjects and methods for the treatment of psychiatric disorders at high altitudes by administering one or more creatine-containing compounds.